BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35714811)

  • 1. The Slc25a47 locus is a novel determinant of hepatic mitochondrial function implicated in liver fibrosis.
    Bresciani N; Demagny H; Lemos V; Pontanari F; Li X; Sun Y; Li H; Perino A; Auwerx J; Schoonjans K
    J Hepatol; 2022 Oct; 77(4):1071-1082. PubMed ID: 35714811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SLC25A47 locus controls gluconeogenesis and energy expenditure.
    Yook JS; Taxin ZH; Yuan B; Oikawa S; Auger C; Mutlu B; Puigserver P; Hui S; Kajimura S
    Proc Natl Acad Sci U S A; 2023 Feb; 120(9):e2216810120. PubMed ID: 36812201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord-derived mesenchymal stem cells ameliorate liver fibrosis by improving mitochondrial function via Slc25a47-Sirt3 signaling pathway.
    Chen P; Yuan M; Yao L; Xiong Z; Liu P; Wang Z; Jiang Y; Li L
    Biomed Pharmacother; 2024 Feb; 171():116133. PubMed ID: 38198960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic mitochondrial NAD + transporter SLC25A47 activates AMPKα mediating lipid metabolism and tumorigenesis.
    Cheng L; Deepak RNVK; Wang G; Meng Z; Tao L; Xie M; Chi W; Zhang Y; Yang M; Liao Y; Chen R; Liang Y; Zhang J; Huang Y; Wang W; Guo Z; Wang Y; Lin JD; Fan H; Chen L
    Hepatology; 2023 Dec; 78(6):1828-1842. PubMed ID: 36804859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy.
    Rochette L; Meloux A; Zeller M; Malka G; Cottin Y; Vergely C
    Molecules; 2020 May; 25(10):. PubMed ID: 32455902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An adipocyte-specific defect in oxidative phosphorylation increases systemic energy expenditure and protects against diet-induced obesity in mouse models.
    Choi MJ; Jung SB; Lee SE; Kang SG; Lee JH; Ryu MJ; Chung HK; Chang JY; Kim YK; Hong HJ; Kim H; Kim HJ; Lee CH; Mardinoglu A; Yi HS; Shong M
    Diabetologia; 2020 Apr; 63(4):837-852. PubMed ID: 31925461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction
    Zhou L; Li Q; Chen A; Liu N; Chen N; Chen X; Zhu L; Xia B; Gong Y; Chen X
    FASEB J; 2019 Dec; 33(12):14254-14269. PubMed ID: 31648561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
    Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
    J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress.
    Yang C; Lu W; Lin T; You P; Ye M; Huang Y; Jiang X; Wang C; Wang F; Lee MH; Yeung SC; Johnson RL; Wei C; Tsai RY; Frazier ML; McKeehan WL; Luo Y
    BMC Gastroenterol; 2013 Apr; 13():67. PubMed ID: 23590285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
    Liu Y; Dou X; Zhou WY; Ding M; Liu L; Du RQ; Guo L; Qian SW; Tang Y; Yang QQ; Pan DN; Li XY; Lu Y; Cheng JK; Tang QQ
    Hepatology; 2021 Oct; 74(4):1864-1883. PubMed ID: 33934381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
    Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term adjustment of hepatic lipid metabolism after chronic stress and the role of FGF21.
    Dille M; Nikolic A; Wahlers N; Fahlbusch P; Jacob S; Hartwig S; Lehr S; Kabra D; Klymenko O; Al-Hasani H; Kotzka J; Knebel B
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166286. PubMed ID: 34624498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress.
    Kim SH; Kim KH; Kim HK; Kim MJ; Back SH; Konishi M; Itoh N; Lee MS
    Diabetologia; 2015 Apr; 58(4):809-18. PubMed ID: 25537833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 21 and exercise-induced hepatic mitochondrial adaptations.
    Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Thyfault JP; Rector RS
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(10):G832-43. PubMed ID: 27012775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
    Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y
    Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyocyte-specific loss of mitochondrial p32/C1qbp causes cardiomyopathy and activates stress responses.
    Saito T; Uchiumi T; Yagi M; Amamoto R; Setoyama D; Matsushima Y; Kang D
    Cardiovasc Res; 2017 Aug; 113(10):1173-1185. PubMed ID: 28498888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Fat Content Is Associated with Fasting-Induced Fibroblast Growth Factor 21 Secretion in Mice Fed Soy Proteins.
    Taniguchi H; Akiyama N; Ishihara K
    J Nutr Sci Vitaminol (Tokyo); 2019; 65(6):515-525. PubMed ID: 31902865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of diurnal energy balance by mitokines.
    Klaus S; Igual Gil C; Ost M
    Cell Mol Life Sci; 2021 Apr; 78(7):3369-3384. PubMed ID: 33464381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic posttranscriptional network comprised of CCR4-NOT deadenylase and FGF21 maintains systemic metabolic homeostasis.
    Morita M; Siddiqui N; Katsumura S; Rouya C; Larsson O; Nagashima T; Hekmatnejad B; Takahashi A; Kiyonari H; Zang M; St-Arnaud R; Oike Y; Giguère V; Topisirovic I; Okada-Hatakeyama M; Yamamoto T; Sonenberg N
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7973-7981. PubMed ID: 30926667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 21 controls mitophagy and muscle mass.
    Oost LJ; Kustermann M; Armani A; Blaauw B; Romanello V
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):630-642. PubMed ID: 30895728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.